Core laboratories n.v. (CLB)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
REVENUES:
Revenue

668,210

700,846

647,819

590,232

797,520

1,085,222

1,073,508

981,080

907,648

794,653

695,539

780,836

OPERATING EXPENSES:
General and administrative expense, exclusive of depreciation expense shown below

48,023

62,910

47,737

39,390

49,729

45,655

51,988

43,185

41,141

33,029

30,372

31,646

Depreciation

20,812

22,013

23,605

25,445

26,545

25,297

24,168

21,762

22,126

21,820

23,106

21,063

Amortization

1,793

1,074

919

843

912

1,399

1,303

1,155

1,177

1,293

712

710

Other (income) expense, net

-5,319

737

-632

400

3,669

-1,069

338

4,121

-919

-2,205

-3,202

-5,580

OPERATING INCOME (LOSS)

96,684

118,622

109,968

87,451

161,070

346,531

333,419

297,280

250,754

226,926

186,782

207,055

Severance and other charges

-

-

-

-

22,943

0

0

-

-

-

-

-

Loss on exchange of Senior Exchangeable Notes

-

-

-

-

-

-

-

-

-1,012

-1,939

0

2,829

Interest expense

14,690

13,328

10,734

11,572

12,380

10,600

9,317

8,820

10,900

15,839

15,523

21,610

Income from continuing operations before income tax expense

81,994

105,294

99,234

75,879

148,690

335,931

324,102

288,460

238,842

209,148

171,259

188,274

Income tax expense (benefit)

-12,290

25,447

18,249

10,855

33,758

77,305

80,908

71,848

54,198

63,747

57,164

56,766

Income (loss) from continuing operations

94,284

79,847

80,985

-65,024

-

-

-

-

-

-

-

-

Income (loss) from discontinued operations, net of income taxes

7,833

-58

2,111

-1,165

-

-

-

-

-

-

-

-

Net income (loss)

102,117

79,789

83,096

63,859

114,932

258,626

243,194

216,612

184,644

145,401

114,095

131,508

Net income (loss) attributable to non-controlling interest

134

263

-29

-36

85

1,141

383

541

-40

484

491

342

Net income (loss) attributable to Core Laboratories N.V.

101,983

79,526

83,125

63,895

114,847

257,485

242,811

216,071

184,684

144,917

113,604

131,166

EARNINGS (LOSS) PER SHARE INFORMATION:
Basic earnings (loss) per share from continuing operations

2.13

1.81

1.83

1.50

-

-

-

-

-

-

-

-

Basic earnings (loss) per share from discontinued operations

0.17

-0.01

0.05

-0.03

-

-

-

-

-

-

-

-

Basic earnings (loss) per share attributable to Core Laboratories N.V.

2.30

1.80

1.88

1.47

2.69

5.80

5.31

4.58

3.99

3.23

2.47

2.85

Diluted earnings (loss) per share from continuing operations

2.11

1.80

1.83

1.49

-

-

-

-

-

-

-

-

Diluted earnings (loss) per share from discontinued operations

0.17

-0.01

0.05

-0.03

-

-

-

-

-

-

-

-

Diluted earnings (loss) per share attributable to Core Laboratories N.V.

2.28

1.79

1.88

1.46

2.68

5.77

5.28

4.54

3.82

3.00

2.43

2.74

Cash dividends per share (in dollar per share)

-

-

-

2.20

2.20

2.00

1.28

1.12

-

0.89

0.57

0.60

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)

44,357

44,206

44,153

43,479

42,747

44,362

45,692

47,211

46,286

44,830

45,939

46,017

Assuming Dilution (in shares)

44,646

44,474

44,264

43,670

42,908

44,600

45,994

47,553

48,393

48,241

46,657

47,887

Service [Member]
Revenue

474,193

486,820

480,264

468,388

611,954

780,872

765,428

693,895

621,752

568,220

529,523

597,695

Cost of services and product sales exclusive of depreciation expense shown below

345,641

343,833

333,365

329,520

387,739

449,488

444,963

413,086

395,303

356,563

333,544

387,145

Product [Member]
Revenue

194,017

214,026

167,555

121,844

185,566

304,350

308,080

287,185

285,896

226,433

166,016

183,141

Cost of services and product sales exclusive of depreciation expense shown below

149,938

153,131

131,593

107,983

144,913

215,783

218,005

208,733

198,066

157,227

124,225

127,637